Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Covidex AB
AB
In liquidation
Org 5592534878
Other research and experimental development on natural sciences and engineering · NACE 7219
Est. 2020
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2021
SEK 53K
EBITDA margin
-17.0%
-200% vs 2020
Equity ratio
95.0%
Financial strength
Net profit 2021
SEK -9K
-200% vs 2020
EBITDA — year on year
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
SEK 53K
—
EBITDA
SEK -9K
-200%
Net profit
SEK -9K
-200%
Total assets
SEK 40K
-15%
Equity
SEK 38K
-19%
Employees
0
—
Company information
Legal name
Covidex AB
Org number
5592534878
Legal form
Aktiebolag
NACE code
7219 · Other research and experimental development on natural sciences and engineering
Founded
24 april 2020
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget ska arbeta med utveckling av läkemedel och medicintekniska produkter och därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other research and experimental development on natural sciences and engineering
Companies in
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
Income statement
SEK thousands
Item
2020
2021
Revenue
0
53
Staff expenses
—
—
EBITDA
−3
−9
Depreciation & amort.
−0
−0
EBIT
−3
−9
Net financials
—
—
Profit before tax
−3
−9
Tax
−0
−0
Net profit
−3
−9
Balance sheet
SEK thousands
Item
2020
2021
Total assets
47
40
Equity
47
38
Long-term debt
0
0
Short-term debt
0
2
Total debt
—
2
Financial ratios
5-year trend
EBITDA margin
-17.0%
This company
15.8%
Market median
-208% vs market
2020
2021
Equity ratio
95.0%
This company
38.2%
Market median
+149% vs market
2020
2021
Return on equity
-23.7%
This company
18.4%
Market median
-229% vs market
2020
2021
Net profit margin
-17.0%
This company
8.1%
Market median
-310% vs market
2020
2021
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
2020
2021
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2020
2021
Annual reports & filings
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MV
Mona Veronica Vesterberg
External Signatory
External Signatory
2022
—
—
AB
Anna Birgitta Emanuelsson
External Signatory
External Signatory
2022
—
—
AE
Anna Elisabeth Adolfsson
Liquidator
Liquidator
2022
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
JK
Jean Kaarlo Lycke
Board of Directors
2022
—
—
MG
Mats Gustav Jontell
Board of Directors
2022
—
—
OG
Olof Gustaf Paulus Isaksson
Board of Directors
2022
—
—
BT
Bengt Thomas Hedner
Chairman
2022
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Covidex AB also hold positions in
0
other companies.
Person
Role here
Other companies
Mona Veronica Vesterberg
External Signatory
0 companies
Anna Birgitta Emanuelsson
External Signatory
0 companies
Anna Elisabeth Adolfsson
Liquidator
0 companies
Jean Kaarlo Lycke
Board of Directors
0 companies
Mats Gustav Jontell
Board of Directors
0 companies
Olof Gustaf Paulus Isaksson
Board of Directors
0 companies
Bengt Thomas Hedner
Chairman
0 companies